Southern Specialty Research

Flowood, Mississippi 39232

2 studies enrolling now · 2 studies all time

What they study most

Sickle Cell Disease

Studies at this site

• Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD) — Recruiting now
• A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) — Recruiting now